| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Timothy Keutzer
Chief Operating Officer
|
58 |
Since 2023
3 years
|
2015 | $1,440,820 | |
|
Debra Zack
Chief Medical Officer
Title from the Form 4 dated Aug 3, 2026
|
Not stated | Not stated | Not stated | Not reported | |
|
Esther Rajavelu
Also a director
See Remarks
Title from the Form 4 dated Nov 6, 2026
|
47 | Not stated | Not stated | $2,061,496 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed Apr 27, 2026 · updated by the 8-K of Nov 10, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Frank E. Thomas
Board chair
|
56 |
2017
9 years
|
Independent | None stated | Larimar Therapeutics Inc. | $187,800 | |
|
Esther Rajavelu
CEO, Executive officer
|
47 |
2025
1 year
|
Not independent | None stated | None stated | Paid as CEO | |
|
Milind Deshpande
|
69 |
2014
12 years
|
Independent | None stated | None stated | Not stated | |
|
Scott Jackson
|
61 |
2020
6 years
|
Independent | None stated | MacroGenics, Inc. | $115,300 | |
|
John C. Pottage, Jr.
|
73 |
2018
8 years
|
Not independent | None stated | None stated | $332,800 | |
|
Cynthia Smith
|
57 |
2019
7 years
|
Independent | None stated | Agios Pharmaceuticals, Inc., Akebia Therapeutics, Inc., Protara Therapeutics, Inc., Tvardi Therapeutics, Inc. | $117,800 | |
|
Kathleen Tregoning
|
55 |
2021
5 years
|
Independent | None stated | None stated | $107,800 | |
|
William Ho
Joined Nov 10, 2026
|
- | - | - |
Development Committee
|
- | - |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
The proxy filed Apr 27, 2026 describes a review policy but reports no transactions.
Read the policy in the proxyLoading...